Opus Genetics, Stock Price Prediction
| IRD Stock | 1.11 0.06 5.71% |
Oversold Vs Overbought
37
Oversold | Overbought |
Using Opus Genetics, hype-based prediction, you can estimate the value of Opus Genetics, from the perspective of Opus Genetics, response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Opus Genetics, to buy its stock at a price that has no basis in reality. In that case, they are not buying Opus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Opus Genetics, after-hype prediction price | USD 1.11 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Opus |
Opus Genetics, After-Hype Price Prediction Density Analysis
As far as predicting the price of Opus Genetics, at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Opus Genetics, or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Opus Genetics,, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Opus Genetics, Estimiated After-Hype Price Volatility
In the context of predicting Opus Genetics,'s stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Opus Genetics,'s historical news coverage. Opus Genetics,'s after-hype downside and upside margins for the prediction period are 0.06 and 5.85, respectively. We have considered Opus Genetics,'s daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Opus Genetics, is extremely dangerous at this time. Analysis and calculation of next after-hype price of Opus Genetics, is based on 3 months time horizon.
Opus Genetics, Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Opus Genetics, is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Opus Genetics, backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Opus Genetics,, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 4.74 | 0.00 | 0.00 | 6 Events / Month | 4 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.11 | 1.11 | 0.00 |
|
Opus Genetics, Hype Timeline
On the 1st of December Opus Genetics, is traded for 1.11. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Opus is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Opus Genetics, is about 1547.76%, with the expected price after the next announcement by competition of 1.11. The company had not issued any dividends in recent years. Considering the 90-day investment horizon the next projected press release will be in about 6 days. Check out Opus Genetics, Basic Forecasting Models to cross-verify your projections.Opus Genetics, Related Hype Analysis
Having access to credible news sources related to Opus Genetics,'s direct competition is more important than ever and may enhance your ability to predict Opus Genetics,'s future price movements. Getting to know how Opus Genetics,'s peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Opus Genetics, may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PVH | PVH Corp | (0.18) | 9 per month | 1.44 | 0.02 | 3.18 | (2.80) | 6.78 | |
| NKE | Nike Inc | 1.27 | 9 per month | 0.00 | (0.11) | 2.37 | (2.31) | 13.61 | |
| MNST | Monster Beverage Corp | (3.45) | 10 per month | 1.43 | 0.07 | 2.51 | (1.35) | 11.37 | |
| CTRN | Citi Trends | 0.01 | 8 per month | 1.93 | 0.14 | 5.18 | (2.97) | 17.32 | |
| NCTW | Nascent Wine | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MJWNY | Naked Wines plc | 0.00 | 0 per month | 0.00 | (0.15) | 0.00 | 0.00 | 7.54 | |
| DWWEF | Diamond Estates Wines | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AEO | American Eagle Outfitters | (0.10) | 8 per month | 0.00 | (0.12) | 3.55 | (4.27) | 10.31 |
Opus Genetics, Additional Predictive Modules
Most predictive techniques to examine Opus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Opus using various technical indicators. When you analyze Opus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Opus Genetics, Predictive Indicators
The successful prediction of Opus Genetics, stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Opus Genetics,, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Opus Genetics, based on analysis of Opus Genetics, hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Opus Genetics,'s market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Opus Genetics,'s related companies.
Story Coverage note for Opus Genetics,
The number of cover stories for Opus Genetics, depends on current market conditions and Opus Genetics,'s risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Opus Genetics, is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Opus Genetics,'s long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Opus Genetics, Short Properties
Opus Genetics,'s future price predictability will typically decrease when Opus Genetics,'s long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Opus Genetics, often depends not only on the future outlook of the potential Opus Genetics,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Opus Genetics,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 24 M |
Complementary Tools for Opus Stock analysis
When running Opus Genetics,'s price analysis, check to measure Opus Genetics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opus Genetics, is operating at the current time. Most of Opus Genetics,'s value examination focuses on studying past and present price action to predict the probability of Opus Genetics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opus Genetics,'s price. Additionally, you may evaluate how the addition of Opus Genetics, to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |